key: cord-0854003-a1akhkle authors: Bayrakdar, Fatma; Kocabas, Can Naci; Altas, Ayse Basak; Kavuncuoglu, H. Gokhan; Cosgun, Yasemin; Mısırlıoglu, Emine Dibek; Durmaz, Ihsan; Korukluoglu, Gulay; Ozkul, Aykut title: Genetic variability human respiratory syncytial virus subgroups A and B in Turkey during six successive epidemic seasons, 2009‐2015 date: 2017-12-06 journal: J Med Virol DOI: 10.1002/jmv.24983 sha: 9ed21829dc619b51fd743cb588b7a89a76d21efd doc_id: 854003 cord_uid: a1akhkle Human respiratory syncytial virus (HRSV) is most important viral respiratory pathogen of acute lower respiratory tract infections in infants and young children worldwide. The circulating pattern and genetic characteristics in the HRSV attachment glycoprotein gene were investigated in Turkey during six consecutive seasons from 2009 to 2015. HRSVA was dominant in the all epidemic seasons except 2011‐2012 season. Partial sequences of the HVR2 region of the G gene of 479 HRSVA and 135 HRSVB were obtained. Most Turkish strains belonged to NA1, ON1, and BA9, which were the predominant genotypes circulating worldwide. Although three novel genotypes, TR‐A, TR‐BA1, and TR‐BA2, were identified, they were not predominant. Clinical data were available for 69 HRSV‐positive patients who were monitored due to acute lower respiratory tract illness. There were no significant differences in the clinical diagnosis, hospitalization rates, laboratory findings and treatment observed between the HRSVA and HRSVB groups, and co‐infections in this study. The major population afflicted by HRSV infections included infants and children between 13 and 24 months of age. We detected that the CB1, GB5, and THB strains clustered in the same branch with a bootstrap value of 100%. CB‐B and BA12 strains clustered in the same branch with a bootstrap value of 65%. The BA11 genotype was clustered in the BA9 genotype in our study. The present study may contribute on the molecular epidemiology of HRSV in Turkey and provide data for HRSV strains circulating in local communities and other regions worldwide. that of non-pandemic influenza virus. Reinfection with HRSV can occur throughout life, and annual epidemics occur during winter months in temperate regions. 3 HRSV (Family: Paramyxoviridae, Ordo: Mononegavirales) is an enveloped virus with a single-stranded, negative sense, nonsegmented RNA genome that is 15.2 kb in length. The viral genome consists of 10 genes, coding for 11 proteins in the following order: NS1, NS2, N, P, M, SH, G, F, M2-1, M2-2, and L. Two groups, HRSVA and HRSVB, have been described based on reactions with monoclonal antibodies against the G and F glycoproteins. 4, 5 The G protein is a type-II integral membrane protein consisting of 289-299 amino acids that facilitates virus attachment to a susceptible cell host. The ectodomain of the G protein consists of two hypervariable regions, HVR1 and HVR2, that are split by a highly conserved 13-amino acid length (aa 155-206) domain. The addition of O-and N-oligosaccharides to G glycoprotein changes its antigenic characteristics. 1,4,6-8 HVR2 region, located at the C-terminal end of protein, commonly used for molecular analyses. It has highest degree of diversity between subgroups and within each subgroup. [4] [5] [6] Until now, considering both antigenic and genetic analysis, 14 genotypes of HRSVA (GA1-GA7, SAA1, CB-A, NA1-NA4, and ON1) 1, [8] [9] [10] [11] [12] [13] and 28 genotypes of HRSVB (BA1-BA13, GB1-GB5, SAB1-SAB4, URU1-2, CB1, BA-C, CB-B, and THB) have been identified. 11, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] The genetic diversity between HRSV genotypes and occurrence of new genotypes may change its pathogenicity and facilitate evasion from existing host immune response. 1, 10, 13 Recently, a novel HRSVA genotype, ON1, with a 72-nucleotide duplication within HVR2 was reported in Canada and disseminated globally. 13 HRSV-positive samples (ct values were between 16 and 32) were then subjected to RT semi-nested PCR to partially amplify the G protein coding region of gRNA for subsequent phylogenetic analysis. For genetic analysis of the HRSVs, the carboxy terminus of the G protein coding region was amplified by using the Qiagen One Step RT-PCR Kit In the second run (semi-nested PCR), 1 μL from the first run PCR products was added into reaction mix containing Taq DNA polymerase (Qiagen). For group A and B viruses, AG655 and BG517 forward primers, respectively, and F164 reverse primers were used as described by Sullender et al. 28 The length of amplified DNA products for A, B, and BA viruses were 450 bp, 585 bp, and 645 bp, respectively. Before nucleotide sequencing, the amplified PCR products were purified using the Qiagen PCR purification kit or Qiagen Qiaquick Gel Extraction Kit (Qiagen) from agarose gel. Cycle sequencing was performed using a BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems) in both directions. Sequence data were generated on the ABI 3130 Genetic Analyzer (Applied Biosystems). Sequences were manually edited, and multiple sequence alignments were generated using the Clustal X 2.012 version. 29 Identical sequences were identified with DAMBE software, version 5.3.10. 30 Alignment of sequences from our study with reference sequences was performed on the ClustalW programme with MEGA6 software. 31 For HRSVA and B, the phylogenetic tree of HVR2 was constructed by the neighbour joining method using the substitution model nucleotide Pdistance, complete deletion for gap or missing data treatment and 1000 replicates of bootstrap probabilities within MEGA 6. The partial nucleotide sequences of G gene, belonging to the six epidemic seasons, were deposited at GenBank under accession numbers KM266805-KM267027 and MF177907-MF177952. The HRSV reference sequences used in this study are shown in Supplement 1A,B. SPSS v12.0 software (SPSS, Inc., Chicago, IL) was used for statistical analysis. The significance of differences in the rates among various groups was tested with the Student's t-test and Fisher's exact test. Statistical significance was considered for a two-sided value of P < 0.05. (Table 1 ). Clinical data were available for 69 HRSV-positive patients who were monitored due to ALRTI, especially bronchiolitis. Of 69 patients, 40 (58%) were male, and the median age was 4.9 months (10 days-180 months) (IQR 25-75%). Also considering the distribution of HRSV positivity according to gender, it was seen that males were more commonly infected than females (Figure 4) . and P distance values smaller than 0.07, the TR-A genotype, belonging to the HRSVA genotype, and TR-BA1 and TR-BA2 genotypes, belonging to HRSVB genotype, were identified in our country between 2009 and 2013. 8 The bootstrap values were 83% for TR-A, 76% for TR-BA1, and 75% for TR-BA2 in clusters. The P-distance values of the clusters were 0.01. Cui et al 13 described a novel genotype from China, named CB1. The CB1 genotype was defined by K224E, R214I, and V251M amino acid substitutions. 13 Partial sequences of the HVR2 region of the G gene of 479 HRSVA and 135 HRSVB were successfully obtained. The mean nucleotide diversity within HRSVA is 0.062 and HRSVB is 0.058. The distribution of genotypes, belonging to each HRSV season, is given in Table 3 HRSV is the most common viral pathogen causing lower respiratory tract infections among infants and young children. 32 The incidence of HRSV-associated bronchiolitis and pneumonia was highest in 2-to 3month-old infants; with increasing age, the incidence decreased. 33 In this study, bronchiolitis was common for both subtypes according to clinical analysis of 69 pediatric patients. A higher susceptibility of HRSV infection occurred at the age of 0-2 years. Most infected The HRSV prevalence decreased to 7.4% in children between 3 and 5 years old. The prevalence of HRSV decreased in children older than 1 year of age. [34] [35] Lower immune response in the early years will develop soonest when children are re-infected for the second or third time. 36 There were no significant differences in the clinical symptoms, similar length of hospitalization, laboratory findings, and treatment observed between the HRSVA and HRSVB groups or in the coinfections in this study. Although any clinical differences between the HRSV genotypes were not reported. 11, 13, 18, [37] [38] [39] Baek et al 11 noted that HRSVB infections had a relatively greater impact on the disease severity. Coinfection had no obvious impact on the disease severity. 11 In our study, males were more commonly infected than females, as mentioned before. 11, [39] [40] [41] RSV causes epidemics in the beginning of winter and spring in temperate climates, but its activity may differ locally. [42] [43] [44] [45] infections appear at the end of November and peak in January in Turkey. Usually, an epidemiological peak is reached at around week 52 in the winter. Considering the genotype analyses, both genotypes co-circulated in six studied epidemic seasons. HRSV group dominance has been reported worldwide; both genotypes should be co-circulated and dominant genotype should be variable. In many studies, HRSVA viruses are more frequently detected. 13 The THB and GB5 genotypes should be classified into the CB1 genotype. We strongly recommend using the CB1 genotype due to the priority rule. A similar issue was detected with the CB-B and BA12 genotypes. 11, 19 CB-B and BA12 strains clustered in the same branch with a bootstrap value of 65% ( Figure 5B ). Additionally, the BA11 genotype was clustered in the BA9 genotype in our study. 23 The present study provides additional information on the molecular epidemiology of HRSV in Turkey and presents data for comparative analysis with HRSV stains circulating in local communities and other regions worldwide. These findings may improve our understanding of HRSV evolution and the potential development of an HRSV vaccine. Fatma Bayrakdar http://orcid.org/0000-0001-7531-5080 Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein Comparison of respiratory syncytial virus humoral immunity and response to infection in young and eldery adults Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies Two distinct subtypes of human respiratory syncytial virus The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community Emerging genotypes of human respiratory syncytial virus subgroup A among patients in Japan Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea Genetic variability of human respiratory syncytial virus a strains circulating in Ontario: a novel genotype with a 72 nucleotide G gene duplication Genetic variation in attachment glycoprotein genes of human respiratory syncytial virus subgroups A and B in children in recent five consecutive years Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides Genotypes of respiratory syncytial virus group B identified in Uruguay Molecular epidemiology of respiratory syncytial virus infections among children with acute respiratory symptoms in a community over three seasons New genotypes within respiratory syncytial virus group B genotype BA in Niigata A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype Displacement of predominant respiratory syncytial virus genotypes in Malaysia between1989 and Molecular characterization of human respiratory syncytial virus, 2010-2011: identification of genotype ON1 and a new subgroup B genotype in Thailand The genetic variability of glycoproteins among respiratory syncytial virus subtype A in China between Molecular characterization of human respiratory syncytial virus subtype B: a novel genotype of subtype B circulating in China Molecular detection and characterization of respiratory syncytial virüs B genotypes circulating in Pakistani children Human respiratory syncytial virus in children with lower respiratory tract infections or influenza-like illness and its co-infection characteristics with viruses and atypical bacteria in Hangzhou Complete genome sequence of human respiratory syncytial virus genotype A with a 72-nucleotide duplication in the attachment protein G gene Rapid replacement of human respiratory syncytial virus A with the ON1 genotype having 72 nucleotide duplication in G gene Molecular characterization of human respiratory syncytial virus in the Philippines Analysis of respiratory syncytial virus genetic variability with amplified cDNAs Clustal W and Clustal X version 2.0 DAMBE5: a comprehensive software package for data analysis in molecular biology and evolution MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods Respiratory syncytial virus genetic and antigenic diversity Infection and disease with respect to age, immunologic status, race and sex Lower respiratory tract disease in children: constant pathogens-constant management? Genetic variability of group a human respiratory syncytial virus strains circulating in Germany from 1998 to Respiratory syncytial virus Molecular epidemiology of respiratory syncytial virüs Correlation between respiratory syncytial virus genotype and severity of illness Molecular evolution and circulation patterns of respiratory syncytial virus subgroup A: positively selected sites in the attachment G glycoprotein Genetic diversity of respiratory syncytial virus isolated during an epidemic period from children of northeastern Brazil Genetic variable of respiratory syncytial virus (RSV) prevalent in southwestern China from 2006 to 2009: emergence of subgroup B and RSV as dominant strains New generations line vaccines agents against human respiratory syncytial virus designed by reverse genetics Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants Respiratory syncytial virus infections: recent prospects for control Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of attachment (G) glycoprotein with a 60-nucleotide duplication Genetic diversity and molecular epidemiology of the G protein of subgroups A and B of respiratory syncytial virus isolated over 9 consecutive epidemics in Korea Premature stop codons in the G glycoprotein of respiratory syncytial viruses resistant to neutralization by monoclonal antibodies Replacement of previously circulating respiratory syncytial virus subtype B strains with the BA genotype in South Africa Additional Supporting Information may be found online in the supporting information tab for this article.